A build-up of plaque in arteries can lead to cardiovascular conditions
SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY
Genetically engineered immune cells could help reduce the clogging of arteries, potentially lowering the risk of heart attack or stroke in people who don’t respond to common treatments.
Doctors often treat those at high risk of these conditions using drugs called statins, but they don’t protect everyone. “If statins were perfect we wouldn’t have such an issue with cardiovascular disease – it’s still the leading cause of death worldwide,“ says Robert Schwab at the University of Pennsylvania.
Felecia Phillips Ollie DD (h.c.) is the inspiring leader and founder of The Equality Network LLC (TEN). With a background in coaching, travel, and a career in news, Felecia brings a unique perspective to promoting diversity and inclusion. Holding a Bachelor’s Degree in English/Communications, she is passionate about creating a more inclusive future. From graduating from Mississippi Valley State University to leading initiatives like the Washington State Department of Ecology’s Equal Employment Opportunity Program, Felecia is dedicated to making a positive impact. Join her journey on our blog as she shares insights and leads the charge for equity through The Equality Network.
